ORGANON & CO. (OGN)
Organon and Samsung Bioepis Expand Agreement to Commercialize PYZCHIVA® (ustekinumab), a Biosimilar Referencing STELARA® (ustekinumab) in Canada
Organon and Samsung Bioepis Expand Agreement to Commercialize PYZCHIVA® (ustekinumab), a Biosimilar Referencing STELARA® (ustekinumab) in Canada
Global Net Lease, Inc. Announces Preferred Stock Dividends
Premier Graphene Inc. (OTC: BIEI) Currently Anticipates Reporting First Profitable Quarter in Company History
NIQ and Ogury Collaborate to Enhance Media Planning and Audience Strategy with GeoPurchase Insights
Alibaba Group Announces Filing of Annual Report on Form 20-F for Fiscal Year 2026
Organon et Samsung Bioepis élargissent leur entente pour la commercialisation de PYZCHIVA® (ustékinumab), un biosimilaire de référence à STELARA® (ustékinumab) au Canada
Cerrado Gold Announces Successful Results of Annual Meeting of Shareholders
Forrester abre el plazo de presentación de candidaturas para sus 2026 B2B Awards en EMEA
Opening of Trading on June 19 2026-FATTAL HOLD B6
Opening of Trading on June 19 2026-TSG B1